239 related articles for article (PubMed ID: 19734774)
21. Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study.
Silverberg MJ; Lau B; Achenbach CJ; Jing Y; Althoff KN; D'Souza G; Engels EA; Hessol NA; Brooks JT; Burchell AN; Gill MJ; Goedert JJ; Hogg R; Horberg MA; Kirk GD; Kitahata MM; Korthuis PT; Mathews WC; Mayor A; Modur SP; Napravnik S; Novak RM; Patel P; Rachlis AR; Sterling TR; Willig JH; Justice AC; Moore RD; Dubrow R;
Ann Intern Med; 2015 Oct; 163(7):507-18. PubMed ID: 26436616
[TBL] [Abstract][Full Text] [Related]
22. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
Gingues S; Gill MJ
HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
[TBL] [Abstract][Full Text] [Related]
23. HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome?
Bower M; Powles T; Newsom-Davis T; Thirlwell C; Stebbing J; Mandalia S; Nelson M; Gazzard B
J Acquir Immune Defic Syndr; 2004 Dec; 37(5):1563-5. PubMed ID: 15577408
[TBL] [Abstract][Full Text] [Related]
24. AIDS-related cancers in the era of highly active antiretroviral therapy.
Biggar RJ
Oncology (Williston Park); 2001 Apr; 15(4):439-48; discussion 448-9. PubMed ID: 11346932
[TBL] [Abstract][Full Text] [Related]
25. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review.
Cobucci RN; Lima PH; de Souza PC; Costa VV; Cornetta Mda C; Fernandes JV; Gonçalves AK
J Infect Public Health; 2015; 8(1):1-10. PubMed ID: 25294086
[TBL] [Abstract][Full Text] [Related]
26. Long-term cancer risk among people diagnosed with AIDS during childhood.
Simard EP; Shiels MS; Bhatia K; Engels EA
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):148-54. PubMed ID: 22068287
[TBL] [Abstract][Full Text] [Related]
27. The pattern of secondary cancers in patients with Kaposi sarcoma in the United States.
Kumar V; Garg M; Chaudhary N; Soni P; Floudas CS; Nwanyanwu C; Chandra A
Cancer Causes Control; 2017 Oct; 28(10):1065-1074. PubMed ID: 28900786
[TBL] [Abstract][Full Text] [Related]
28. Reduced incidence of Kaposi's sarcoma and of systemic non-hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy.
Carrieri MP; Pradier C; Piselli P; Piche M; Rosenthal E; Heudier P; Durant J; Serraino D
Int J Cancer; 2003 Jan; 103(1):142-4. PubMed ID: 12455069
[No Abstract] [Full Text] [Related]
29. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.
Vilchez RA; Finch CJ; Jorgensen JL; Butel JS
Medicine (Baltimore); 2003 Mar; 82(2):77-81. PubMed ID: 12640183
[TBL] [Abstract][Full Text] [Related]
30. Noninfectious pulmonary complications of HIV/AIDS.
Kanmogne GD
Curr Opin Pulm Med; 2005 May; 11(3):208-12. PubMed ID: 15818181
[TBL] [Abstract][Full Text] [Related]
31. Incidence and time trends of anal cancer among people living with HIV in Australia.
Jin F; Vajdic CM; Law M; Amin J; van Leeuwen M; McGregor S; Poynten IM; Templeton DJ; Grulich AE
AIDS; 2019 Jul; 33(8):1361-1368. PubMed ID: 30950880
[TBL] [Abstract][Full Text] [Related]
32. Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD).
Petoumenos K; van Leuwen MT; Vajdic CM; Woolley I; Chuah J; Templeton DJ; Grulich AE; Law MG;
HIV Med; 2013 Feb; 14(2):77-84. PubMed ID: 22934689
[TBL] [Abstract][Full Text] [Related]
33. Less cancer--or more--with HAART? Or, reflections on a late opus.
Mascolini M
J Int Assoc Physicians AIDS Care; 1998 Jun; 4(6):12-22. PubMed ID: 11365531
[TBL] [Abstract][Full Text] [Related]
34. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
[TBL] [Abstract][Full Text] [Related]
35. Anal cancers among HIV-infected persons: HAART is not slowing rising incidence.
Crum-Cianflone NF; Hullsiek KH; Marconi VC; Ganesan A; Weintrob A; Barthel RV; Agan BK;
AIDS; 2010 Feb; 24(4):535-43. PubMed ID: 19926961
[TBL] [Abstract][Full Text] [Related]
36. The effects of HAART on AIDS-related Kaposi's sarcoma and non-Hodgkin's lymphoma.
Clayton G; Omasta-Martin A; Bower M
J HIV Ther; 2006 Sep; 11(3):51-3. PubMed ID: 17580498
[No Abstract] [Full Text] [Related]
37. Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults.
Jaffe HW; De Stavola BL; Carpenter LM; Porter K; Cox DR;
AIDS; 2011 Jul; 25(11):1395-403. PubMed ID: 21572307
[TBL] [Abstract][Full Text] [Related]
38. Cancer risk among participants in the women's interagency HIV study.
Hessol NA; Seaberg EC; Preston-Martin S; Massad LS; Sacks HS; Silver S; Melnick S; Abulafia O; Levine AM;
J Acquir Immune Defic Syndr; 2004 Aug; 36(4):978-85. PubMed ID: 15220706
[TBL] [Abstract][Full Text] [Related]
39. Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States.
Robbins HA; Shiels MS; Pfeiffer RM; Engels EA
AIDS; 2014 Mar; 28(6):881-90. PubMed ID: 24300545
[TBL] [Abstract][Full Text] [Related]
40. Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort.
Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
Int J Cancer; 2015 Nov; 137(10):2443-53. PubMed ID: 25976897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
